Nucleix Ltd. Revenue and Competitors
Estimated Revenue & Valuation
- Nucleix Ltd.'s estimated annual revenue is currently $12.9M per year.
- Nucleix Ltd.'s estimated revenue per employee is $155,000
- Nucleix Ltd.'s total funding is $83M.
Employee Data
- Nucleix Ltd. has 83 Employees.
- Nucleix Ltd. grew their employee count by 8% last year.
Nucleix Ltd. Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Nucleix Ltd.?
Nucleix is a global leader in creating cancer diagnostic panels based on epigenetic bio markers. Backed by OrbiMed and other leading investors, Nucleix provides a strong pipeline of products for various cancer types.
keywords:N/A
$83M
Total Funding
83
Number of Employees
$12.9M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Nucleix Ltd.'s People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Senior Scientist | Reveal Email/Phone |
3 | CLIA Laboratory Manager | Reveal Email/Phone |
4 | Senior Bioinformatics Research Scientist | Reveal Email/Phone |
5 | VP Product Development | Reveal Email/Phone |
6 | Research Scientist | Reveal Email/Phone |
7 | Associate Director, Laboratory Operations | Reveal Email/Phone |
8 | VP, Clincal Affairs | Reveal Email/Phone |
9 | Senior Director, Clinical Operations | Reveal Email/Phone |
10 | Executive Director Information Technology | Reveal Email/Phone |
Nucleix Ltd. News
It’s full steam ahead for Nucleix’s blood test for lung cancer detection, thanks to an influx of cash in the Israeli company’s latest round of funding. Free Infographic Download 7 Areas to Evaluate When Selecting Your Clinical Adjudication Partner Clinical trials can include an independent unb ...
San Diego-based Nucleix, a startup which is developing liquid biopsy technology for early detection of lung cancer, has raised $55M in a funding round, the company announced this morning. The company said the funding was led by RA Capital Management, and also included BlackRock, Lilly Asia Ventu ...
Nucleix, a Rehovot, Israel- and San Diego, CA-based liquid biopsy company, secured $55m in funding. The round was led by RA Capital Management, with participation from new investors including funds and accounts managed by BlackRock, Lilly Asia Ventures, LYFE Capital and MILFAM. Existing investo ...
Other Companies in Rehovot
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $12.9M | 83 | 2% | N/A |
#2 | $13.5M | 87 | 4% | N/A |
#3 | $25.9M | 103 | -10% | N/A |
#4 | $35.1M | 108 | 24% | N/A |
#5 | $32.4M | 120 | -10% | N/A |